Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Cel-Sci In Meltdown As Investors Unconvinced By CEO’s Spin On Drug Failure
Refutes Accusations Of Data Manipulation
Jul 08 2021
•
By
Andrew McConaghie
Cel-Sci has been around for nearly 40 years without launching a product, but looks to be running out of options. • Source: Alamy
More from Business
More from Scrip